Trials / Conditions / Intracranial Arteriosclerosis

Intracranial Arteriosclerosis

13 registered clinical trials studyying Intracranial Arteriosclerosis — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Randomized Trial of the Rapamycin Target Eluting Stent for the Treatment of Symptomatic Cerebral Artery Athe NCT06925971	MicroPort NeuroTech Co., Ltd.	Phase 3
Withdrawn	Comparison Three vs Six Months of Dual Anti-platelet Therapy After Sirolimus-eluting Stent Implantation NCT06857045	Sino Medical Sciences Technology Inc.	N/A
Not Yet Recruiting	Pair Antiplatelet THerapy in Ischemic Stroke With Intracranial Artery Stenosis NCT06243133	Sichuan Provincial People's Hospital	Phase 4
Recruiting	A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in C NCT05692882	Sino Medical Sciences Technology Inc.	N/A
Completed	Evaluating the Safety and Efficacy of the Maurora® DES in ICAS NCT05719883	Beijing Tiantan Hospital	N/A
Not Yet Recruiting	Remote Ischemic Conditioning Combined With Endovascular Stenting for Symptomatic Intracranial Atherosclerotic NCT05653505	Tianjin Huanhu Hospital	—
Active Not Recruiting	Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis NCT05047172	University of Florida	Phase 3
Completed	A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers NCT04103034	Band Therapeutics	Phase 1
Unknown	Intracranial Stenting in Non-acute Symptomatic Ischemic Stroke NCT05063630	Can Tho Stroke International Services Hospital	N/A
Withdrawn	Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis NCT04325932	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 4
Completed	Stroke Imaging Package Study NCT02485275	Wei-Hai Xu	—
Completed	Identifying the Anti-Blood-Clotting Compounds in Garlic NCT00200785	National Center for Complementary and Integrative Health (NCCIH)	N/A
Terminated	Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up NCT00000600	National Heart, Lung, and Blood Institute (NHLBI)	Phase 2